Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New group therapy aims to help people with anxiety face the unknown

NCT ID NCT04512378

Symptom relief Sponsor: University of Manitoba Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jul 30, 2026 · Updated 3 times

Summary

This pilot study is testing a group-based cognitive-behavioural therapy (CBT) for people with generalized anxiety disorder (GAD) who have difficulty tolerating uncertainty. The treatment focuses on helping participants face uncertain situations through behavioural experiments. The study will include 12-20 adults with GAD and high intolerance of uncertainty, and will assess whether a future larger trial is feasible.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
group-based cognitive-behavioural therapy
What this could lead to
If successful, this could show that a group format of this therapy is feasible and effective, making it easier to offer to more people with generalized anxiety disorder.
What could go wrong
This is a very small pilot study (12-20 participants) that is currently suspended. It is designed only to test feasibility, not to prove the treatment works.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

6 people

The number who actually took part.

Started

Feb 2021

Finished

Jun 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 89 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Primary diagnosis of generalized anxiety disorder (GAD) * High Intolerance of uncertainty (IU) Exclusion Criteria: * Comorbid psychosis, organic brain disorder, bipolar disorder, or current substance use disorder * Receiving concurrent psychological treatments or other counselling * Psychotropic medications must remain stable during the study period and for 3 months prior to intervention

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Anxiety are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

anxiety anxiety disorder generalized anxiety disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Anxiety Generalized anxiety disorder Intolerance of uncertainty

Contacts and locations

Locations

  • Deer Lodge Centre

    Winnipeg, Manitoba, R3J 0L3, Canada

  • St. Boniface General Hospital

    Winnipeg, Manitoba, R2H 2A6, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.